SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-011914
Filing Date
2024-05-01
Accepted
2024-05-01 19:02:18
Documents
1
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 form4-05012024_110511.html 4  
1 form4-05012024_110511.xml 4 7731
  Complete submission text file 0001415889-24-011914.txt   9178
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Hohl Benjamin (Reporting) CIK: 0001882764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 24904584